Attention: This platform is in beta mode. Expect some changes and adjustments.

AI Market Mood: Stock Dashboard

XRX


Fundamental

Company: Xerox Holdings Corp
Sector: Technology
Industry: Information Technology Services
Country: USA
Exchange: NASD
Index: RUT
P/E: -
EPS (ttm): -10.55
Insider Own: 7.64%
Shs Outstand: 125.78M
Perf Week: 10.12%
Market Cap: 670.46M
Forward P/E: 3.33
EPS next Y: 1.60
Insider Trans: 0.86%
Shs Float: 116.17M
Perf Month: -4.65%
Income: -1312.00M
PEG: -
EPS next Q: 0.07
Inst Own: 94.94%
Short Float: 21.87%
Perf Quarter: -14.86%
Sales: 6.18B
P/S: 0.11
EPS this Y: -23.71%
Inst Trans: -2.78%
Short Ratio: 5.24
Perf Half Y: -39.36%
Book/sh: 8.37
P/B: 0.64
EPS next Y Percentage: 116.22%
ROA: -14.30%
Short Interest: 25.41M
Perf Year: -61.29%
Cash/sh: 2.91
P/C: 1.83
EPS next 5Y: -
ROE: -67.27%
52W Range From: 3.44
52W Range To: 14.81
Perf YTD: -36.77%
Dividend Est.: 0.50 (9.38%)
P/FCF: 1.50
EPS past 5Y: -
ROIC: -31.89%
52W High: -64.01%
Beta: 1.85
Dividend TTM: 0.88 (16.42%)
Quick Ratio: 0.77
Sales past 5Y: -7.26%
Gross Margin: 29.39%
52W Low: 54.72%
ATR (14): 0.31
Dividend Ex-Date: Jun 30, 2025
Current Ratio: 1.09
EPS Y/Y TTM: -575.59%
Oper. Margin: 2.64%
RSI (14): 57.23
Volatility W: 2.20%
Volatility M: 4.50%
Employees: 16800
Debt/Eq: 2.77
Sales Y/Y TTM: -7.49%
Profit Margin: -21.24%
Recom: 3.25
Target Price: 5.50
Option/Short: Yes / Yes
LT Debt/Eq: 2.25
EPS Q/Q: 20.47%
Payout: -
Rel Volume: 0.49
Prev Close: 5.13
Sales Surprise: 1.06%
EPS Surprise: -55.04%
Sales Q/Q: -3.00%
Earnings: May 01 BMO
Avg Volume: 4.85M
Price: 5.33
SMA20: 3.09%
SMA50: 12.57%
SMA200: -31.76%
Trades:
Volume: 2,380,580
Change: 3.90%

Technical:


Latest News:

Recursion Announces Completion of NVIDIA-Powered BioHive-2, - GlobeNewswire somewhat bullish
RXRX

Summary: Recursion announced the completion of BioHive-2, a new NVIDIA DGX SuperPOD AI supercomputer, resulting in four times faster speeds than their original supercomputer in benchmark performance tests. This supercomputer will accelerate their use of a growing dataset for training new AI models and advancing drug discovery efforts.

Full article
2024-05-13T09:02:04Z
Lexicon Pharmaceuticals to Participate in the Bank of America Securities Healthcare ... neutral
LXRX

Summary: Lexicon Pharmaceuticals, Inc. announced its participation in the Bank of America Securities Healthcare Conference 2024 where its president and chief financial officer will make a company presentation. The simultaneous webcast will be available on the company's website.

Full article
2024-05-09T11:55:59Z
Nvidia Owns a 3.4% Stake in This Innovative Artificial Intelligence (AI) Stock ... - Yahoo Finance somewhat bullish
RXRX

Summary: Nvidia owns a 3.4% stake in Recursion Pharmaceuticals, a biotech company using AI for drug discovery. Recursion aims to improve the drug discovery process by reducing costs and moving faster. The company already has partnerships with Roche and Bayer.

Full article
2024-04-27T19:36:16Z
Nvidia Owns a 3.4% Stake in This Innovative Artificial Intelligence (AI) Stock Cathie Wood Loves neutral
NVDA RXRX

Summary: Nvidia disclosed its portfolio of AI stocks surpassing $100 million, with a concentration on ARM Holdings and a 3.4% stake in Recursion Pharmaceuticals. Recursion aims to improve drug discovery using AI and big data, with partnerships in place with Roche and Bayer.

Full article
2024-04-27T16:35:54Z
Nvidia Owns a 3.4% Stake in This Innovative Artificial Intelligence (AI) Stock Cathie Wood Loves somewhat bullish
NVDA RXRX

Summary: Nvidia has over $100 million in portfolio of AI stocks, with a significant investment in ARM Holdings and a 3.4% stake in Recursion Pharmaceuticals. Recursion focuses on using AI to improve drug discovery process, with potential to become Nvidia's biggest investment if successful. However, investing in Recursion is considered a risky bet due to its high R&D expenses and ongoing cash burn.

Full article
2024-04-27T13:29:36Z
Nvidia Owns a 3.4% Stake in This Innovative Artificial Intelligence (AI) Stock Cathie Wood Loves somewhat bullish
NVDA RXRX

Summary: Nvidia has made a sizable investment in AI stocks, with Recursion Pharmaceuticals being one of its key holdings as they use AI for drug discovery process.

Full article
2024-04-27T13:02:12Z
Short IBM and Go Long on Xerox. - Globe Echo neutral
IBM XRX

Summary: The market correction is expected to see a bounce to the upside before further declines, with IBM's earnings report anticipated to lead to a decline in the stock price, while Xerox's report is expected to lift the share price.

Full article
2024-04-22T11:09:48Z